BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹15,359 Cr | ₹8,511 Cr | ₹3,828 Cr | ₹4,210 Cr | ₹4,008 Cr |
What is the latest Total Current Liabilities ratio of BIOCON ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹15,359 Cr |
Mar2023 | ₹8,511 Cr |
Mar2022 | ₹3,828 Cr |
Mar2021 | ₹4,210 Cr |
Mar2020 | ₹4,008 Cr |
How is Total Current Liabilities of BIOCON Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹15,359 Cr | 80.46 | |
Mar2023 | ₹8,511 Cr | 122.33 | |
Mar2022 | ₹3,828 Cr | -9.08 | |
Mar2021 | ₹4,210 Cr | 5.04 | |
Mar2020 | ₹4,008 Cr | - |
Compare Total Current Liabilities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹39,373.7 Cr | -3.9% | 4.2% | 27.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -3.9% |
4.2% |
27.9% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses